We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
(-25%)
Cap. Flow
-$5.59B
Cap. Flow
% of AUM
-19.76%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$97.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$95.6M |
| 3 |
Cheniere Energy
LNG
|
+$94.4M |
| 4 |
Visa
V
|
+$92.5M |
| 5 |
AstraZeneca
AZN
|
+$88.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$204M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$196M |
| 3 |
NVIDIA
NVDA
|
+$131M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$130M |
| 5 |
Marathon Petroleum
MPC
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 13.09% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Applied Industrial Technologies
AIT
$12.4B
| $23.5M | 0.08% |
244,463
+157,793
| +182% | +$15.9M |
|
277
Criteo S.A. Ordinary Shares
CRTO
$1.14B
| $23.4M | 0.08% |
959,256
+1,547
| +0.2% | +$39.3K |
|
278
ICF International
ICFI
$1.5B
| $23.3M | 0.08% |
245,324
+91,850
| +60% | +$8.92M |
|
279
Constellation Energy
CEG
$92.1B
| $23.3M | 0.08% |
406,176
-318,824
| -44% | -$19.2M |
|
280
Progressive
PGR
$128B
| $23.3M | 0.08% |
200,000
-35,634
| -15% | -$4.04M |
|
281
CarGurus
CARG
$3.34B
| $22.7M | 0.08% |
1,056,790
-209,263
| -17% | -$6.19M |
|
282
Bausch + Lomb
BLCO
$5.78B
| $22.7M | 0.08% |
+1,488,059
| New | +$24.1M |
|
|
DRE
283
DELISTED
Duke Realty Corp.
DRE
| $22.5M | 0.08% |
409,070
-56,980
| -12% | -$3.12M |
|
284
Williams-Sonoma
WSM
$27.5B
| $22.3M | 0.08% |
402,190
-972,814
| -71% | -$62.9M |
|
285
Cencora
COR
$62B
| $22.3M | 0.08% |
157,565
-59,290
| -27% | -$9.07M |
|
286
Kimco Realty
KIM
$17.5B
| $22.3M | 0.08% |
1,126,930
+53,638
| +5% | +$1.23M |
|
287
Camden Property Trust
CPT
$11.5B
| $22M | 0.08% |
163,750
-18,960
| -10% | -$2.81M |
|
288
Pool Corp
POOL
$7.05B
| $21.4M | 0.08% |
60,900
-39,700
| -39% | -$15.7M |
|
289
Axalta
AXTA
$7.45B
| $21.3M | 0.08% |
962,015
+2,874
| +0.3% | +$73.1K |
|
290
Burlington
BURL
$23.4B
| $21.2M | 0.07% |
155,407
+722
| +0.5% | +$131K |
|
|
MRTX
291
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21M | 0.07% |
313,295
+5,010
| +2% | +$319K |
|
292
Rush Enterprises Class A
RUSHA
$6.34B
| $20.5M | 0.07% |
639,003
-1,076,068
| -63% | -$36M |
|
293
Sensata Technologies
ST
$6.69B
| $20.3M | 0.07% |
490,660
+36,016
| +8% | +$1.66M |
|
294
Otis Worldwide
OTIS
$27.9B
| $20.3M | 0.07% |
286,662
-21,760
| -7% | -$1.6M |
|
295
Wabtec
WAB
$49.3B
| $20M | 0.07% |
243,100
-297,137
| -55% | -$26.5M |
|
296
Harley-Davidson
HOG
$2.61B
| $19.9M | 0.07% |
627,032
-35,990
| -5% | -$1.28M |
|
297
Aecom
ACM
$9.46B
| $19.7M | 0.07% |
302,200
+9,530
| +3% | +$666K |
|
298
Synaptics
SYNA
$4.05B
| $19.7M | 0.07% |
166,767
-113,178
| -40% | -$16.6M |
|
299
Duolingo
DUOL
$6.53B
| $19.7M | 0.07% |
224,518
+7,701
| +4% | +$680K |
|
300
Intellia Therapeutics
NTLA
$1.51B
| $19.4M | 0.07% |
375,399
+12,649
| +3% | +$642K |
|
Similar funds
Lord, Abbett & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.
- Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
- Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
- Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
- Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
- Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
- Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
- Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.
Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.